Notice of Results
TheraCryf plc has announced that its half-year results for the six months ending 30 September 2025 will be released on Wednesday, 3 December 2025. A live presentation of these results will be conducted at 11 am GMT on the same day via Investor Meet Company, featuring the CEO, CFO, and COO. This presentation is open to all current and potential shareholders, who can submit questions up to 24 hours in advance or during the live event.
Select text to share a quote on X · sign in to keep highlights & notes in your TCF notes
Alderley Park, 24 November 2025 - TheraCryf plc (AIM: TCF), the clinical stage drug development company focussing on neuropsychiatry and oncology, announces that the Company's half year results for the six months to 30 September 2025 will be released on Wednesday, 3 December 2025.
A live presentation of the results will be given at 11am GMT on 3 December, via Investor Meet Company by Dr Huw Jones, CEO, Toni Hänninen, CFO and Dr Helen Kuhlman, COO.
The results presentation will be open to all existing and potential shareholders. Questions can be submitted up to 24 hours prior to either event via the Investor Meet Company dashboard or during the live presentations.
Investors who already follow TheraCryf plc on the Investor Meet Company platform will automatically be invited. New registrants can sign up to Investor Meet Company HERE.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.